[Skip to Content]

Upstate Active Clinical Trials

Study Title:

A PHASE 3, MULTI-CENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF RELDESEMTIV IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS (ALS)

Upstate Institutional Review Board (IRB) Number:

1679698

Patient Age Group:

Adults

Principal Investigator:

Deborah Y Bradshaw

Who can I contact for more information?

Name: Sigiriya E Smolen
Phone: 315-464-9767
Email: smolens@upstate.edu

Return to Previous Page || Search Again

Top